Ridgewood Investments’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11K | Hold |
72
| – | – | ﹤0.01% | 637 |
|
|
2025
Q1 | $1.07K | Hold |
72
| – | – | ﹤0.01% | 633 |
|
|
2024
Q4 | $953 | Hold |
72
| – | – | ﹤0.01% | 638 |
|
|
2024
Q3 | $1.02K | Sell |
72
-6,828
| -99% | -$97.1K | ﹤0.01% | 651 |
|
|
2024
Q2 | $89.3K | Buy |
+6,900
| New | +$89.3K | 0.04% | 252 |
|
|
2023
Q3 | – | Sell |
-6,900
| Closed | -$108K | – | 688 |
|
|
2023
Q2 | $108K | Sell |
6,900
-32,561
| -83% | -$512K | 0.06% | 233 |
|
|
2023
Q1 | $650K | Hold |
39,461
| – | – | 0.4% | 72 |
|
|
2022
Q4 | $616K | Sell |
39,461
-3
| -0% | -$47 | 0.44% | 76 |
|
|
2022
Q3 | $512K | Buy |
39,464
+6,014
| +18% | +$78K | 0.43% | 79 |
|
|
2022
Q2 | $470K | Buy |
33,450
+72
| +0.2% | +$1.01K | 0.37% | 95 |
|
|
2022
Q1 | $478K | Buy |
33,378
+5,353
| +19% | +$76.7K | 0.31% | 107 |
|
|
2021
Q4 | $382K | Buy |
+28,025
| New | +$382K | 0.24% | 128 |
|